Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma

Abstract Clear cell renal cell carcinoma (ccRCC) has been previously classified into putative discrete prognostic subtypes by gene expression profiling. To investigate the robustness of these proposed subtype classifications, we evaluated 12 public datasets, together with a new dataset of 265 ccRCC...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiaona Wei, Yukti Choudhury, Weng Khong Lim, John Anema, Richard J. Kahnoski, Brian Lane, John Ludlow, Masayuki Takahashi, Hiro-omi Kanayama, Arie Belldegrun, Hyung L. Kim, Craig Rogers, David Nicol, Bin Tean Teh, Min-Han Tan
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8b092046f8544ac887a7010827752cf4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8b092046f8544ac887a7010827752cf4
record_format dspace
spelling oai:doaj.org-article:8b092046f8544ac887a7010827752cf42021-12-02T16:06:48ZRecognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma10.1038/s41598-017-07191-y2045-2322https://doaj.org/article/8b092046f8544ac887a7010827752cf42017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-07191-yhttps://doaj.org/toc/2045-2322Abstract Clear cell renal cell carcinoma (ccRCC) has been previously classified into putative discrete prognostic subtypes by gene expression profiling. To investigate the robustness of these proposed subtype classifications, we evaluated 12 public datasets, together with a new dataset of 265 ccRCC gene expression profiles. Consensus clustering showed unstable subtype and principal component analysis (PCA) showed a continuous spectrum both within and between datasets. Considering the lack of discrete delineation and continuous spectrum observed, we developed a continuous quantitative prognosis score (Continuous Linear Enhanced Assessment of RCC, or CLEAR score). Prognostic performance was evaluated in independent cohorts from The Cancer Genome Atlas (TCGA) (n = 414) and EMBL-EBI (n = 53), CLEAR score demonstrated both superior prognostic estimates and inverse correlation with anti-angiogenic tyrosine-kinase inhibition in comparison to previously proposed discrete subtyping classifications. Inverse correlation with high-dose interleukin-2 outcomes was also observed for the CLEAR score. Multiple somatic mutations (VHL, PBRM1, SETD2, KDM5C, TP53, BAP1, PTEN, MTOR) were associated with the CLEAR score. Application of the CLEAR score to independent expression profiling of intratumoral ccRCC regions demonstrated that average intertumoral heterogeneity exceeded intratumoral expression heterogeneity. Wider investigation of cancer biology using continuous approaches may yield insights into tumor heterogeneity; single cell analysis may provide a key foundation for this approach.Xiaona WeiYukti ChoudhuryWeng Khong LimJohn AnemaRichard J. KahnoskiBrian LaneJohn LudlowMasayuki TakahashiHiro-omi KanayamaArie BelldegrunHyung L. KimCraig RogersDavid NicolBin Tean TehMin-Han TanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Xiaona Wei
Yukti Choudhury
Weng Khong Lim
John Anema
Richard J. Kahnoski
Brian Lane
John Ludlow
Masayuki Takahashi
Hiro-omi Kanayama
Arie Belldegrun
Hyung L. Kim
Craig Rogers
David Nicol
Bin Tean Teh
Min-Han Tan
Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma
description Abstract Clear cell renal cell carcinoma (ccRCC) has been previously classified into putative discrete prognostic subtypes by gene expression profiling. To investigate the robustness of these proposed subtype classifications, we evaluated 12 public datasets, together with a new dataset of 265 ccRCC gene expression profiles. Consensus clustering showed unstable subtype and principal component analysis (PCA) showed a continuous spectrum both within and between datasets. Considering the lack of discrete delineation and continuous spectrum observed, we developed a continuous quantitative prognosis score (Continuous Linear Enhanced Assessment of RCC, or CLEAR score). Prognostic performance was evaluated in independent cohorts from The Cancer Genome Atlas (TCGA) (n = 414) and EMBL-EBI (n = 53), CLEAR score demonstrated both superior prognostic estimates and inverse correlation with anti-angiogenic tyrosine-kinase inhibition in comparison to previously proposed discrete subtyping classifications. Inverse correlation with high-dose interleukin-2 outcomes was also observed for the CLEAR score. Multiple somatic mutations (VHL, PBRM1, SETD2, KDM5C, TP53, BAP1, PTEN, MTOR) were associated with the CLEAR score. Application of the CLEAR score to independent expression profiling of intratumoral ccRCC regions demonstrated that average intertumoral heterogeneity exceeded intratumoral expression heterogeneity. Wider investigation of cancer biology using continuous approaches may yield insights into tumor heterogeneity; single cell analysis may provide a key foundation for this approach.
format article
author Xiaona Wei
Yukti Choudhury
Weng Khong Lim
John Anema
Richard J. Kahnoski
Brian Lane
John Ludlow
Masayuki Takahashi
Hiro-omi Kanayama
Arie Belldegrun
Hyung L. Kim
Craig Rogers
David Nicol
Bin Tean Teh
Min-Han Tan
author_facet Xiaona Wei
Yukti Choudhury
Weng Khong Lim
John Anema
Richard J. Kahnoski
Brian Lane
John Ludlow
Masayuki Takahashi
Hiro-omi Kanayama
Arie Belldegrun
Hyung L. Kim
Craig Rogers
David Nicol
Bin Tean Teh
Min-Han Tan
author_sort Xiaona Wei
title Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma
title_short Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma
title_full Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma
title_fullStr Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma
title_full_unstemmed Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma
title_sort recognizing the continuous nature of expression heterogeneity and clinical outcomes in clear cell renal cell carcinoma
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/8b092046f8544ac887a7010827752cf4
work_keys_str_mv AT xiaonawei recognizingthecontinuousnatureofexpressionheterogeneityandclinicaloutcomesinclearcellrenalcellcarcinoma
AT yuktichoudhury recognizingthecontinuousnatureofexpressionheterogeneityandclinicaloutcomesinclearcellrenalcellcarcinoma
AT wengkhonglim recognizingthecontinuousnatureofexpressionheterogeneityandclinicaloutcomesinclearcellrenalcellcarcinoma
AT johnanema recognizingthecontinuousnatureofexpressionheterogeneityandclinicaloutcomesinclearcellrenalcellcarcinoma
AT richardjkahnoski recognizingthecontinuousnatureofexpressionheterogeneityandclinicaloutcomesinclearcellrenalcellcarcinoma
AT brianlane recognizingthecontinuousnatureofexpressionheterogeneityandclinicaloutcomesinclearcellrenalcellcarcinoma
AT johnludlow recognizingthecontinuousnatureofexpressionheterogeneityandclinicaloutcomesinclearcellrenalcellcarcinoma
AT masayukitakahashi recognizingthecontinuousnatureofexpressionheterogeneityandclinicaloutcomesinclearcellrenalcellcarcinoma
AT hiroomikanayama recognizingthecontinuousnatureofexpressionheterogeneityandclinicaloutcomesinclearcellrenalcellcarcinoma
AT ariebelldegrun recognizingthecontinuousnatureofexpressionheterogeneityandclinicaloutcomesinclearcellrenalcellcarcinoma
AT hyunglkim recognizingthecontinuousnatureofexpressionheterogeneityandclinicaloutcomesinclearcellrenalcellcarcinoma
AT craigrogers recognizingthecontinuousnatureofexpressionheterogeneityandclinicaloutcomesinclearcellrenalcellcarcinoma
AT davidnicol recognizingthecontinuousnatureofexpressionheterogeneityandclinicaloutcomesinclearcellrenalcellcarcinoma
AT binteanteh recognizingthecontinuousnatureofexpressionheterogeneityandclinicaloutcomesinclearcellrenalcellcarcinoma
AT minhantan recognizingthecontinuousnatureofexpressionheterogeneityandclinicaloutcomesinclearcellrenalcellcarcinoma
_version_ 1718384853687205888